DIA Annual Canadian Meeting October 19-20 Virtual

This year's DIA Annual Canadian Meeting will be forward-looking with analysis of innovations and advances that promise to speed review and approval and enhance patient access to drugs and health products in Canada. From advancing agile regulation of innovative new products to the expanding use of RWE for safety and efficacy regulatory decision-making to enhancements that shorten the access continuum, industry, regulatory, and HTA stakeholders will share their perspectives on next steps to sustain progress. 

In addition to policy updates and priorities shared directly from Health Canada, regulators and industry will discuss lessons learned from the response to the COVID-19 crisis, as well as impact of the pandemic on the path ahead for drugs and health products in Canada. At the DIA Annual Canadian Meeting, you will have the exclusive opportunity to address the current issues in Canada and across the globe. 


©2020 by Patient Engagement by CanBiotech Innovations
Partner and Advertise with CanBiotech
Contact Us    Privacy and Security Statement
1 King Street W,  Suite 4800-97
Toronto, ON

M5H 1A1